A

APT Medical Inc
SSE:688617

Watchlist Manager
APT Medical Inc
SSE:688617
Watchlist
Price: 351.41 CNY -1.27% Market Closed
Market Cap: 34.2B CNY
Have any thoughts about
APT Medical Inc?
Write Note

APT Medical Inc
Net Issuance of Debt

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

APT Medical Inc
Net Issuance of Debt Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Net Issuance of Debt CAGR 3Y CAGR 5Y CAGR 10Y
A
APT Medical Inc
SSE:688617
Net Issuance of Debt
ÂĄ29.7m
CAGR 3-Years
N/A
CAGR 5-Years
26%
CAGR 10-Years
N/A
J
Jiangsu Yuyue Medical Equipment & Supply Co Ltd
SZSE:002223
Net Issuance of Debt
-ÂĄ1.2B
CAGR 3-Years
N/A
CAGR 5-Years
-134%
CAGR 10-Years
N/A
Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760
Net Issuance of Debt
-ÂĄ21.5m
CAGR 3-Years
63%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
J
Jafron Biomedical Co Ltd
SZSE:300529
Net Issuance of Debt
-ÂĄ126.5m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
L
Lepu Medical Technology Beijing Co Ltd
SZSE:300003
Net Issuance of Debt
ÂĄ959.2m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Shanghai United Imaging Healthcare Co Ltd
SSE:688271
Net Issuance of Debt
ÂĄ4.1m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

APT Medical Inc
Glance View

Market Cap
33.9B CNY
Industry
Health Care

APT Medical Inc. is a company embedded in the intricate world of medical devices, specializing in the development, production, and distribution of cardiovascular and peripheral vascular medical products. The company’s foundation rests on its ability to innovate and provide solutions that address the complex challenges faced by healthcare professionals in the treatment of heart and vascular diseases. APT Medical strategically focuses on minimally invasive technologies, which are increasingly preferred for their reduced patient recovery times and overall improvement in procedural success rates. By keeping its pulse on the evolving demands within the healthcare sector, APT Medical efficiently aligns its research and development initiatives to meet the global standards and expectations. Revenue streams for APT Medical Inc. flow primarily from its broad portfolio of interventional medical devices, such as guidewires, balloon catheters, and vascular closure devices. The intricacy of their manufacturing processes, coupled with stringent regulatory requirements, ensures that their offerings are both high in quality and competitively priced. Through a network of strategic partnerships, distribution channels, and a robust export framework, the company extends its reach across several international markets. By maintaining a keen focus on customer service and post-market support, APT Medical not only thrives on initial sales but also secures a steady stream of revenue from recurring purchases and long-term partnerships with healthcare institutions globally.

Intrinsic Value
342.32 CNY
Overvaluation 3%
Intrinsic Value
Price
A

See Also

What is APT Medical Inc's Net Issuance of Debt?
Net Issuance of Debt
29.7m CNY

Based on the financial report for Dec 31, 2023, APT Medical Inc's Net Issuance of Debt amounts to 29.7m CNY.

What is APT Medical Inc's Net Issuance of Debt growth rate?
Net Issuance of Debt CAGR 5Y
26%

Over the last year, the Net Issuance of Debt growth was 342%.

Back to Top